UNITY Biotechnology, Inc. Reports First Quarter 2019 Financial Results
May 08, 2019 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, May 08, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. to Announce First Quarter 2019 Financial Results
April 29, 2019 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, April 29, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Program Updates
March 06, 2019 08:00 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, March 06, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. to Participate in the Cowen 39th Annual Health Care Conference
March 04, 2019 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, March 04, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
CORRECTING and REPLACING -- UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2018 Financial Results
February 27, 2019 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Feb. 27, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline on February 25th by UNITY Biotechnology, Inc. [Nasdaq: UBX], please note that in the first paragraph of...
UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2018 Financial Results
February 25, 2019 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [Nasdaq: UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology Expands Ongoing UBX0101 Phase 1 Study to Further Evaluate SASP Factors in Osteoarthritis of the Knee
January 22, 2019 16:05 ET
|
Unity Biotechnology, Inc.
- Results expected in the second quarter of 2019 - SAN FRANCISCO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics...
UNITY Biotechnology Announces Completion of UBX1967 License and Advance into IND-Enabling Studies for Age-Related Diseases of the Eye
January 03, 2019 16:52 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend human healthspan by slowing, halting or...
UNITY Biotechnology Announces Additional Cohort to Evaluate Higher Dose in Ongoing UBX0101 Phase 1 Study in Osteoarthritis of the Knee
December 03, 2018 17:30 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...